Trailing-twelve-month (TTM) revenue is $183.53 Million with a year-over-year growth of (7.81%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $47,956,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-07 |
| Q4 FY2025Period ended 2025-12-31 | $46,408,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-13 |
| Q1 FY2026Period ended 2026-03-31 | $44,935,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-11 |
| Q2 FY2026Period ended 2026-06-30 | $44,232,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-07 |
| TTM revenue | $183,531,000 |
Current P/S: $50,282,592 market capitalization ÷ $183,531,000 TTM revenue = 0.27x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T20:00:01.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $44.23M.
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 19 comparable quarters.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T22:01:27.787Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|
| Dietary Supplements | $32M | $38M | $36M | $43M |
| Other Service Revenue | N/A | $697,000 | $2M | $3M |
| Product Revenue | $163M | $183M | $192M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|
| All Other Country | $434,000 | $735,000 | $1M | N/A |
| Non-US | N/A | N/A | N/A | $1M |
| UNITED STATES | $165M | $182M | $196M |
$183.53M
$183.53 Million
(7.81%)
vs. $199.08M a year ago (TTM)
+10.52%
5 Year compound annual growth rate
1 Year
(7.81%)
3 Year
(0.12%)
5 Year
+10.52%
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $192.22M | ($4.97M) | (2.52%) |
| 2024 | $197.19M | +$11.83M | +6.38% |
| 2023 | $185.36M | +$20.40M | +12.37% |
| 2022 | $164.96M | +$25.56M | +18.34% |
| 2021 | $139.40M | +$22.83M | +19.58% |
| 2020 |
TTM Growth
(7.81%)
3-Year CAGR
(0.12%)
5-Year CAGR
+10.52%
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T22:01:27.787Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| Service Revenue | $2M | $3M | $5M | $5M |
|---|
| Training Service Revenue | $973,000 | $1M | $1M | $1M |
|---|
| $116.57M |
| +$6.59M |
| +5.99% |
